The Morning Blend


Neurocrine Biosciences

Posted at 10:49 AM, Oct 12, 2020
and last updated 2020-10-12 10:49:33-04

We are living in an unprecedented time, where everyone’s mental health is being put to the test. This October, right before World Mental Health Day (October 10th) and during Mental Illness Awareness Week (October 4-10th), the world renowned Me2/Orchestra and Neurocrine Biosciences will launch the charitable initiative and community platform, Monumental Moments™. The cornerstone of the initiative will be the creation and unveiling of an original musical score created by the Boston-based Me2/Orchestra, the world’s only known classical music organization created for individuals with mental illness and the people who support them. The orchestra’s members have shared their personal stories – challenges, successes, and how they have coped during the pandemic to help inspire and shape the score that will act as the soundtrack for these unprecedented times.


Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company with 28 years of experience discovering and developing life-changing treatments for people with serious, challenging and under-addressed neurological, endocrine and psychiatric disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, Parkinson’s disease, endometriosis* and uterine fibroids*, with three pivotal and five mid-stage clinical programs in multiple therapeutic areas. Headquartered in San Diego, Neurocrine Biosciences specializes in targeting and interrupting disease-causing mechanisms involving the interconnected pathways of the nervous and endocrine systems. For more information, visit, and follow the company on LinkedIn. (*in collaboration with AbbVie)